It also accords with studies that indicate inconclusive effects of APOE e4 at younger ages on cognitive and brain-imaging markers [51, 52], although there is evidence for an effect of e4 (especially for e4e4 homozygotes) on poorer brain white matter health in middle to older aged people without dementia [53]. This evidence concerns the gene APOE and dementia.